MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

MediBeacon-FDA-GFR

More Like This

PR Newswire associated0

MediBeacon® Transdermal GFR System receives device approval in China

First Irish patient implanted with innovative heart failure management system from Irish Company FIRE1

PR Newswire associated0

Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States

PR Newswire associated0

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

PR Newswire associated0

LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

PR Newswire associated0

LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System

Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function

PR Newswire associated0

MedHub-AI and Terumo partner to market AI-based FFR in Japan